Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-105848
Filing Date
2024-10-03
Accepted
2024-10-03 16:15:12
Documents
1
Period of Report
2024-10-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2425499-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2425499-2_4seq1.xml 4 3989
  Complete submission text file 0001104659-24-105848.txt   5627
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Issuer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 5005 MCCONNELL AVENUE LOS ANGELES CA 90066
Business Address
House David Duane (Reporting) CIK: 0002034219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37544 | Film No.: 241351668